» Articles » PMID: 12631663

Increased Rectal Mucosal Expression of Interleukin 1beta in Recently Acquired Post-infectious Irritable Bowel Syndrome

Overview
Journal Gut
Specialty Gastroenterology
Date 2003 Mar 13
PMID 12631663
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Chronic bowel disturbances resembling irritable bowel syndrome (IBS) develop in approximately 25% of patients after an episode of infectious diarrhoea. Although we have previously shown that psychosocial factors operating at the time of, or prior to, the acute illness appear to predict the development of post-infectious IBS (PI-IBS), our finding of an increased inflammatory cell number in the rectum persisting for at least three months after the acute infection suggested that there is also an organic component involved in the development of PI-IBS. To evaluate this further, we measured expressions of interleukin 1beta (IL-1beta) and its receptor antagonist (IL-1ra) in these patients to provide additional evidence that the pathogenesis of PI-IBS is underpinned by an inflammatory process.

Methods: Sequential rectal biopsy samples were prospectively obtained during and three months after acute gastroenteritis, from eight patients who developed post-infectious IBS (INF-IBS) and seven patients who returned to normal bowel habits after acute gastroenteritis (infection controls, INF-CON). Eighteen healthy volunteers who had not suffered from gastroenteritis in the preceding two years served as normal controls (NOR-CON). IL-1beta and IL-1ra gene expressions were assayed by reverse transcriptase-polymerase chain reaction, and their levels of expression were quantitated by optical densitometry after electrophoresis on agarose gel.

Results: INF-IBS patients exhibited significantly greater expression of IL-1beta mRNA in rectal biopsies than INF-CON patients both during and three months after acute gastroenteritis. Moreover, IL-1beta mRNA expression had increased in biopsies taken from INF-IBS patients at three months after the acute infection but no consistent change was observed in INF-CON patients. IL-1beta mRNA expression of INF-IBS patients at three months post gastroenteritis was significantly greater than NOR-CON whereas that of INF-CON patients was not significantly different from NOR-CON. Despite these differential changes in IL-1beta mRNA expression, no significant changes were observed in IL-1ra mRNA expression among the three groups.

Conclusions: These findings indicate that those patients who develop IBS post infection exhibit greater IL-1beta mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS. We conclude that such patients may be susceptible to inflammatory stimuli, and that inflammation may play a role in the pathogenesis of PI-IBS.

Citing Articles

Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms.

Nakagawa Y, Yamada S Mol Cell Biochem. 2024; .

PMID: 39503802 DOI: 10.1007/s11010-024-05153-3.


Cimifugin improves intestinal barrier dysfunction by upregulating SIRT1 to regulate the NRF2/HO-1 signaling pathway.

Zhang H, Xiong Z, He Y, Su H, Jiao Y Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39302422 DOI: 10.1007/s00210-024-03433-9.


Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.

Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S Microorganisms. 2023; 11(10).

PMID: 37894027 PMC: 10609453. DOI: 10.3390/microorganisms11102369.


Chlorogenic Acid Ameliorates Post-Infectious Irritable Bowel Syndrome by Regulating Extracellular Vesicles of Gut Microbes.

Zheng C, Zhong Y, Zhang W, Wang Z, Xiao H, Zhang W Adv Sci (Weinh). 2023; 10(28):e2302798.

PMID: 37616338 PMC: 10558682. DOI: 10.1002/advs.202302798.


Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review.

Lupu V, Ghiciuc C, Stefanescu G, Mihai C, Popp A, Sasaran M World J Gastroenterol. 2023; 29(21):3241-3256.

PMID: 37377581 PMC: 10292139. DOI: 10.3748/wjg.v29.i21.3241.


References
1.
Gwee K, Leong Y, Graham C, McKendrick M, Collins S, Walters S . The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999; 44(3):400-6. PMC: 1727402. DOI: 10.1136/gut.44.3.400. View

2.
Rodriguez L, Ruigomez A . Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999; 318(7183):565-6. PMC: 27756. DOI: 10.1136/bmj.318.7183.565. View

3.
Qiu B, Vallance B, Blennerhassett P, Collins S . The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med. 1999; 5(10):1178-82. DOI: 10.1038/13503. View

4.
Spiller R, Jenkins D, Thornley J, Hebden J, Wright T, Skinner M . Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6):804-11. PMC: 1728147. DOI: 10.1136/gut.47.6.804. View

5.
Barbara G, De Giorgio R, Deng Y, Vallance B, Blennerhassett P, Collins S . Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology. 2001; 120(7):1729-36. DOI: 10.1053/gast.2001.24847. View